Healthcare Equipment and Supplies
Company Overview of HyperBranch Medical Technology, Inc.
HyperBranch Medical Technology, Inc., a medical device company, develops and markets products primarily for the traumatic or surgically induced wound market. It offers OcuSeal, a liquid ocular bandage for direct application on the surface of the eye to form an ocular bandage, thereby covering an opening in the eye and providing an immediate protective barrier; and Adherus Dural Sealant, which is used as an aid in dural repair in cranial and spinal surgeries, such as the treatment of intracranial aneurysms, tumors, and spinal disc disease. The company also provides Adherus Hernia Mesh Fixation, a device used as a replacement for tacks, staples, sutures, and 'O' rings in hernia repair procedur...
800-12 Capitola Drive
Durham, NC 27713-4410
Founded in 2003
Key Executives for HyperBranch Medical Technology, Inc.
Co-Founder and Chief Scientific Officer
Compensation as of Fiscal Year 2013.
HyperBranch Medical Technology, Inc. Key Developments
HyperBranch Medical Technology, Inc. Completes Patient Enrollment in the Adherus Dural Sealant U.S. Pivotal Clinical Trial
Sep 24 12
HyperBranch Medical Technology, Inc. announced that it has completed patient enrollment in the Adherus(TM) Dural Sealant U.S. pivotal clinical trial, a controlled, randomized trial comparing the Adherus(TM) Dural Sealant in neurosurgery patients, to the only other approved sealant for these procedures. Over 240 patients were treated in the trial. Patients will be followed for four months to evaluate the safety and effectiveness of Adherus, following which, the data will be submitted to the FDA for review as part of the PMA submission. In addition to their proprietary sealant, the Company offers a novel delivery technology which offers high levels of effectiveness and efficiency. It is the first self-contained bioadhesive spray applicator that eliminates preparation steps and allows for effortless and precise start and stop dispensing without concern for clogging. Adherus AutoSpray is CE Marked and has been commercially available in test markets internationally since May 2012. HyperBranch also announced that the company has received FDA IDE approval to begin a pivotal clinical trial for the Adherus(TM) Dural Sealant in spinal applications. HyperBranch will be using their proprietary 1.5 ml Minimally Invasive Applicator in this trial, allowing surgeons who perform MIS procedures to have a dedicated device with the same innovative sealant used in the neurosurgery procedures. Open spinal surgeries will have the option of using the current 6 ml AutoSpray applicator. Both of these spine products have been recently made available in select international markets.
Similar Private Companies By Industry
Recent Private Companies Transactions
April 30, 2013
Most Searched Private Companies
Sponsored Financial Commentaries